STAT

APRIL 7, 2024

SAN DIEGO — Cancer cases among younger people have been rising for years, a trend researchers have struggled to explain. New evidence suggests a significant factor: younger generations seem to be aging faster at the cellular level than their predecessors. A team of scientists at Washington University in St. Louis tracked data from nearly 150,000 people between the ages of 37 and 54 in the U.K.

362

362

Drug Patent Watch

APRIL 7, 2024

Annual Drug Patent Expirations for RELISTOR Relistor is a drug marketed by Salix Pharms and Salix and is included in two NDAs. It is available from one supplier.

98

98

STAT

APRIL 7, 2024

SAN DIEGO — For decades, the Food and Drug Administration’s accelerated approval pathway has helped companies get drugs for serious unmet medical needs to patients — and the market — sooner. But about half of cancer drugs approved via this route fail to improve patient survival or quality of life in subsequent clinical trials after more than five years of follow-up , according to new findings presented Sunday at the American Association for Cancer Research annual meet

318

318

pharmaphorum

APRIL 7, 2024

FDA approves earlier use of J&J's BCMA CAR-T therapy Carvykti and BMS' rival Abecma for earlier use in multiple myeloma

79

79

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

APRIL 7, 2024

A controversial heart pump from Abiomed reduced the number of deaths in severe heart attack patients, according to a highly anticipated randomized trial presented at the American College of Cardiology conference and published in the New England Journal of Medicine on Sunday. The trial, which took 10 years to enroll, followed 355 patients for 180 days in Denmark, Germany, and the United Kingdom who came into the hospital with a heart attack and dangerously low blood flow, known as cardiogenic sho

Hospitals 270

Hospitals 270

Pharmacy Joe

APRIL 7, 2024

In this episode, I’ll discuss the risk of bacteremia in patients with asymptomatic bacteriuria and altered mental status. Episode 911: But They Have Altered Mental Status So We Have To Treat Subscribe on iTunes , Android , or Stitcher Perhaps one of the most frustrating scenarios dealing with antimicrobial stewardship is that of a patient with asymptomatic bacteriuria (meaning no systemic signs of infection) but altered mental status.

Inpatient 59

Inpatient Hospitals 59

PharmaTech

APRIL 7, 2024

Explore QualTrak to find the right bioanalytical tools by modality, phase, and applications. Optimize biopharmaceutical drug development with suggested efficient workflows supported by consistent assays & reagents manufactured under GMP manufacturing principles, automated instruments, premium service & support, and a vertically integrated supply chain.

Drug Development 52

Drug Development 52

STAT

APRIL 7, 2024

ATLANTA — New trial results show that a drug candidate from Alnylam Pharmaceuticals can lead to long-lasting blood pressure reduction when taken with certain commonly used pills, but some doctors are questioning how much the drug would actually be used in clinical practice. Zilebesiran, a novel RNA interference drug dosed every six months, is intended to address a long-standing problem: despite the availability of cheap pills to lower blood pressure, there are still high rates of uncontro

236

236

Med Ed 101

APRIL 7, 2024

For approximately 40 years, botulinum toxin has been used to treat various neuromuscular disorders, but it is not without risk. After all, the risk is in the name (botulinum toxin) and is often enough to make providers and patients wary of tapping into the therapeutic benefits of botulinum toxin. In this article, we will share […] The post What Pharmacists Should Know About Botox appeared first on Med Ed 101.

52

52

Drug Patent Watch

APRIL 7, 2024

Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one NDA. It is available from one supplier.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmacy Times

APRIL 7, 2024

Data for generalized anxiety disorders and cannabis use is scarce, but pharmacists can help educate patients on potential benefits and risks of cannabis usage.

63

63

PharmExec

APRIL 7, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmacy Times

APRIL 7, 2024

Potential adjunctive and novel treatment options based on a patient's specific symptoms and clinical factors are being explored to treat treatment-resistant schizophrenia

55

55

RX Note

APRIL 7, 2024

Introduction Infantile colic is a benign, self-limited process in which a healthy infant has paroxysms of inconsolable crying. The standard diagnostic criteria - known as the "rule of three" (or Wessel Criteria) is crying more than 3 hours per day, more than 3 days per week, for longer than 3 weeks. Symptoms typically resolve by 3 to 6 months of age.

Community Pharmacies 40

Community Pharmacies 40

Pharmacy Times

APRIL 7, 2024

Developments in glycine transporter type 1 inhibitors, D-amino acid oxidase inhibitors, and phosphodiesterase inhibitors are pushing schizophrenia research forward.

55

55

PharmaTech

APRIL 7, 2024

Webinar Date/Time: Wed, May 15, 2024 2:00 PM EDT

52

52

Pharmacy Times

APRIL 7, 2024

The abstracts will be presented at the American College of Cardiology Conference from April 6 to April 8, 2024, in Atlanta, Georgia.

Diabetes 49

Diabetes 49

STAT

APRIL 7, 2024

A new analysis published Sunday challenges the clinical trial endpoint the cancer screening firm Grail is using to evaluate its blood test aimed at simultaneously detecting multiple types of tumors early. Grail’s test, called Galleri, is available in the U.S. but not yet approved by the Food and Drug Administration or reimbursed by Medicare except as part of a particular clinical trial.

288

288

Pharmacy Times

APRIL 7, 2024

Expert perspective on current research, treatment approaches, and clinical considerations for pharmacologic management of borderline personality disorder

Clinic Management 52

Clinic Management 52

Drug Patent Watch

APRIL 7, 2024

This chart shows the pharmaceutical companies with the most patents in Japan.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmacy Times

APRIL 7, 2024

The results further confirm earlier findings from the EMPA-KIDNEY trial.

48

48

RX Note

APRIL 7, 2024

Introduction Cutaneous warts are small, rough growths that are caused by infection of skin cells with certain strains of the human papillomavirus (HPV). More than 100 HPV subtypes are known, giving rise to a variety of presentations. They can appear anywhere on the skin, but are most commonly seen on the hands and feet. A verruca (also known as a plantar wart) is a wart on the sole of the foot.

Compounding 52

Compounding Immunity Immunization Community Pharmacies 52

PharmaState Academy

APRIL 7, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

PharmaState Academy

APRIL 7, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

PharmaState Academy

APRIL 7, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

PharmaState Academy

APRIL 7, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

PharmaState Academy

APRIL 7, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

PharmaState Academy

APRIL 7, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52